Advisor Group Holdings, Inc. Anavex Life Sciences Corp. Transaction History

Advisor Group Holdings, Inc.

  • $42.1 Billion
  • Q1 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 41,868 shares of AVXL stock, worth $316,522. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,868
Previous 3,035 1279.51%
Holding current value
$316,522
Previous $32,000 1021.88%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$7.85 - $13.46 $304,839 - $522,692
38,833 Added 1279.51%
41,868 $359,000
Q4 2024

Feb 07, 2025
SELL
$5.11 - $12.56 $29,377 - $72,207
-5,749 Reduced 65.45%
3,035 $32,000
Q3 2024

Nov 13, 2024
BUY
$4.11 - $7.04 $26,493 - $45,379
6,446 Added 275.71%
8,784 $49,000
Q2 2024

Aug 13, 2024
SELL
$3.39 - $5.02 $36,361 - $53,844
-10,726 Reduced 82.1%
2,338 $9,000
Q1 2024

May 10, 2024
SELL
$4.55 - $6.75 $38,474 - $57,078
-8,456 Reduced 39.29%
13,064 $66,000
Q4 2023

Feb 12, 2024
BUY
$5.04 - $9.95 $43,298 - $85,480
8,591 Added 66.45%
21,520 $200,000
Q3 2023

Nov 13, 2023
SELL
$6.55 - $9.37 $1,395 - $1,995
-213 Reduced 1.62%
12,929 $84,000
Q2 2023

Aug 10, 2023
SELL
$7.66 - $9.5 $12,654 - $15,694
-1,652 Reduced 11.17%
13,142 $106,000
Q1 2023

May 12, 2023
SELL
$8.32 - $11.75 $15,342 - $21,667
-1,844 Reduced 11.08%
14,794 $126,000
Q4 2022

Feb 10, 2023
BUY
$7.65 - $14.43 $54,047 - $101,947
7,065 Added 73.8%
16,638 $154,000
Q3 2022

Nov 14, 2022
SELL
$8.9 - $12.86 $16,135 - $23,315
-1,813 Reduced 15.92%
9,573 $99,000
Q2 2022

Aug 10, 2022
SELL
$7.31 - $12.84 $41,264 - $72,481
-5,645 Reduced 33.15%
11,386 $114,000
Q1 2022

May 04, 2022
SELL
$9.74 - $17.69 $366,857 - $666,293
-37,665 Reduced 68.86%
17,031 $294,000
Q3 2021

Nov 05, 2021
BUY
$16.82 - $25.75 $381,713 - $584,370
22,694 Added 70.91%
54,696 $981,000
Q2 2021

Aug 02, 2021
BUY
$10.16 - $28.86 $222,067 - $630,793
21,857 Added 215.45%
32,002 $722,000
Q1 2021

May 13, 2021
BUY
$5.17 - $16.13 $19,428 - $60,616
3,758 Added 58.84%
10,145 $152,000
Q4 2020

Feb 10, 2021
SELL
$4.01 - $7.58 $15,438 - $29,183
-3,850 Reduced 37.61%
6,387 $35,000
Q3 2020

Nov 12, 2020
SELL
$3.8 - $5.0 $10,450 - $13,750
-2,750 Reduced 21.18%
10,237 $46,000
Q2 2020

Aug 14, 2020
SELL
$2.62 - $5.2 $1,179 - $2,340
-450 Reduced 3.35%
12,987 $64,000
Q1 2020

May 18, 2020
BUY
$2.38 - $5.81 $31,980 - $78,068
13,437 New
13,437 $42,000

Others Institutions Holding AVXL

# of Institutions
203
Shares Held
31M
Call Options Held
1.3M
Put Options Held
662K
View Full List

About ANAVEX LIFE SCIENCES CORP.

AVXL Quotes by TradingView
  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $589M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email